Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zivo Bioscience, Inc. - Common Stock (NQ: ZIVO )

N/A UNCHANGED
Last Price Updated: 1:00 PM EST, Nov 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.110 (2)
Ask (Size) 1.130 (2)
Prev. Close 1.100
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 3,546,335
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q1 2024
Zivo Bioscience just reported results for the first quarter of 2024. 
Via InvestorPlace
SMCI Stock Alert: Super Micro Computer Joins the S&P 500 Today
Super Micro Computer stock is rising on Monday as shares of SMCI join the S&P 500 after an amazing year of growth amid the AI boom. 
Via InvestorPlace
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities

Performance

More News

Read More
ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023
Via InvestorPlace
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
From Zivo Bioscience, Inc.
Via Business Wire
ZIVO Bioscience Announces Uplisting to OTCQB Market
From Zivo Bioscience, Inc.
Via Business Wire
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
From Zivo Bioscience, Inc.
Via Business Wire
11 Consumer Staples Stocks Moving In Thursday's Intraday Session
Via Benzinga
$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
From Zivo Bioscience, Inc.
Via Business Wire
ZIVO Bioscience Announces Reverse Stock Split
From Zivo Bioscience, Inc.
Via Business Wire
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
11 Consumer Staples Stocks Moving In Thursday's Intraday Session
Via Benzinga
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
From Zivo Bioscience, Inc.
Via GlobeNewswire
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
From Zivo Bioscience, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
From Zivo Bioscience, Inc.
Via Business Wire
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
From Zivo Bioscience, Inc.
Via Business Wire
Top 5 Defensive Stocks Which Could Rescue Your Portfolio For July
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
From Zivo Bioscience, Inc.
Via Business Wire
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.